awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39959245-05D59945-5311-4C15-B89C-0B24F1A0227F
Q39959245-05D59945-5311-4C15-B89C-0B24F1A0227F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39959245-05D59945-5311-4C15-B89C-0B24F1A0227F
Synergic antitumoral effect of an IGF-IR inhibitor and trastuzumab on HER2-overexpressing breast cancer cells.
P2860
Q39959245-05D59945-5311-4C15-B89C-0B24F1A0227F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39959245-05D59945-5311-4C15-B89C-0B24F1A0227F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1d2daf7202d2122d5e8dc6e8653ab3715d437425
P2860
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro.